Reuters UK |
AstraZeneca: Asthma drug trial results positive
MarketWatch LONDON–AstraZeneca PLC (AZN.LN) said Tuesday its potential new medicine benralizumab showed positive results in a Phase III trial for asthma treatment. The treatment "was well tolerated and achieved the primary endpoint in two pivotal Phase III … AstraZeneca boosted by good results for biotech asthma drug Astrazeneca Reports Results On Benralizumab Phase III Programme In Severe Asthma TOP NEWS: AstraZeneca Gets Positive Benralizumab Phase III Trial Results |
View full post on asthma – Google News